In order to explore the role of POLR2A in the progression of GC in vivo, we successfully constructed a stable MKN-45 cell line that knocked down POLR2A and its control (Figure 5A), and then performed tumorigenesis experiment in nude mice. The gene discussed is POLR2A; the disease is gastric cancer.